JP2018199726A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018199726A5 JP2018199726A5 JP2018179866A JP2018179866A JP2018199726A5 JP 2018199726 A5 JP2018199726 A5 JP 2018199726A5 JP 2018179866 A JP2018179866 A JP 2018179866A JP 2018179866 A JP2018179866 A JP 2018179866A JP 2018199726 A5 JP2018199726 A5 JP 2018199726A5
- Authority
- JP
- Japan
- Prior art keywords
- abraxane
- medicament
- plinabulin
- medicament according
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims 16
- 229940028652 Abraxane Drugs 0.000 claims 9
- RCINICONZNJXQF-MZXODVADSA-N Intaxel Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 claims 9
- 229960001592 Paclitaxel Drugs 0.000 claims 9
- UNRCMCRRFYFGFX-TYPNBTCFSA-N (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione Chemical group N1C=NC(\C=C/2C(NC(=C\C=3C=CC=CC=3)/C(=O)N\2)=O)=C1C(C)(C)C UNRCMCRRFYFGFX-TYPNBTCFSA-N 0.000 claims 7
- 229950011498 Plinabulin Drugs 0.000 claims 5
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 206010017758 Gastric cancer Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010035226 Plasma cell myeloma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 201000007270 liver cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 201000009251 multiple myeloma Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
Claims (14)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018179866A JP2018199726A (en) | 2018-09-26 | 2018-09-26 | Cancer treatment with combination of plinabulin and taxane |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018179866A JP2018199726A (en) | 2018-09-26 | 2018-09-26 | Cancer treatment with combination of plinabulin and taxane |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016547208A Division JP6411523B2 (en) | 2013-10-11 | 2013-10-11 | Combination cancer treatment of plinabulin and taxane |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018199726A JP2018199726A (en) | 2018-12-20 |
| JP2018199726A5 true JP2018199726A5 (en) | 2019-03-14 |
Family
ID=64667835
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018179866A Pending JP2018199726A (en) | 2018-09-26 | 2018-09-26 | Cancer treatment with combination of plinabulin and taxane |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2018199726A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022552011A (en) * | 2019-10-15 | 2022-12-14 | ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド | Methods and compositions for treating iron disorders |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1711487A1 (en) * | 2004-02-04 | 2006-10-18 | Nereus Pharmaceuticals, Inc. | Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| CA2683973A1 (en) * | 2007-04-13 | 2008-10-23 | Abraxis Bioscience, Inc. | Sparc and methods of use thereof |
| WO2015051543A1 (en) * | 2013-10-11 | 2015-04-16 | Dalian Wanchun Biotechnology Co., Ltd. | Cancer treatment with combination of plinabulin and taxane |
-
2018
- 2018-09-26 JP JP2018179866A patent/JP2018199726A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Murray et al. | Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. | |
| JP2016528162A5 (en) | ||
| KR20170084034A (en) | Use of azelnidipine in preparing medicinal composition for treating cancers | |
| JP2016536352A5 (en) | ||
| JP2021091695A5 (en) | ||
| JP2016536286A5 (en) | ||
| JP2016513657A5 (en) | ||
| JP2009539769A5 (en) | ||
| JP2020523359A5 (en) | ||
| JP2015536964A5 (en) | ||
| RU2016112608A (en) | TREATMENT OF CANCER BY THE COMBINATION OF PLINABULIN AND TAXAN | |
| JP2020509024A5 (en) | ||
| JP2008514577A5 (en) | ||
| JP2009506054A5 (en) | ||
| JP2020523354A5 (en) | ||
| JP2014524469A5 (en) | ||
| JP2020523355A5 (en) | ||
| JP2020516646A5 (en) | ||
| JP2016515586A5 (en) | ||
| JP2015507020A5 (en) | ||
| JP2016526021A5 (en) | ||
| JP2010500284A5 (en) | ||
| JP2020515523A5 (en) | ||
| JP2018199726A5 (en) | ||
| RU2012108144A (en) | ANTI-CANCER THERAPY DIRECTED AGAINST CANCER STEM CELLS AND CANCER FORMS RESISTANT TO TREATMENT BY MEDICINES |